Pisa syndrome in Parkinson disease

Michele Tinazzi, Alfonso Fasano, Christian Geroin, Francesca Morgante, Roberto Ceravolo, Simone Rossi, Astrid Thomas, Giovanni Fabbrini, Anna Rita Bentivoglio, Filippo Tamma, Giovanni Cossu, Nicola Modugno, Mario Zappia, Maria Antonietta Volontè, Carlo Dallocchio, Giovanni Abbruzzese, Claudio Pacchetti, Roberto Marconi, Giovanni Defazio, Margherita CanesiAntonino Cannas, Antonio Pisani, Rina Mirandola, Paolo Barone, Carmine Vitale, R. Allocca, T. Altavilla, G. Bisoffi, F. Bombieri, F. Bove, T. Bovi, L. Cerbarano, C. Cordano, R. Di Giacomo, F. Di Stefano, R. Erro, S. Gallerini, M. Gandolfi, A. F. Gigante, I. Juergenson, F. Lena, L. M. Leocani, V. Lucchese, G. Madeo, S. Mazzucchi, M. Moccia, A. Nicoletti, S. Ottaviani, G. Pezzoli, G. Santangelo, M. Sarchioto, F. Schena, M. Sciarretta, N. Smania, P. Solla, F. Spagnolo, M. Ulivelli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

48 Citazioni (Scopus)


Objective: To estimate the prevalence of Pisa syndrome (PS) in patients with Parkinson disease (PD) and to assess the association between PS and demographic and clinical variables. Methods: In this multicenter cross-sectional study, consecutive outpatients with PD attending 21 movement disorders Italian tertiary centers were enrolled and underwent standardized clinical evaluation. PS was defined as trunk lateral deviation 10. Patients with PD were compared according to the presence of PS for several demographic and clinical variables. Results: Among 1,631 enrolled patients with PD, PS was detected in 143 patients (8.8%, 95% confidence interval 7.4%-10.3%). Patients with PS were older, had lower body mass index, longer disease duration, higher disease stages, and poorer quality of life. Falls were more frequent in the PS group as well as occurrence of "veering gait" (i.e., the progressive deviation toward one side when patient walked forward and backward with eyes closed). Patients with PS received higher daily levodopa equivalent daily dose and were more likely to be treated with combination of levodopa and dopamine agonists. Osteoporosis and arthrosis were significantly the most frequent associatedmedical conditions in patients with PS. Multiple explanatory variable logistic regression models confirmed the association of PSwith the following variables: Hoehn and Yahr stage, ongoing combined treatment with levodopa and dopamine agonist, associated medical conditions, and presence of veering gait. Conclusions: Our results suggest that PS is a relatively frequent and often disabling complication in PD, especially in the advanced disease stages. The association is dependent on a number of potentially relevant demographic and clinical variables.
Lingua originaleEnglish
pagine (da-a)1769-1779
Numero di pagine11
Stato di pubblicazionePubblicato - 2015


  • Aged
  • Cohort Studies
  • Cross-Sectional Studies
  • Dopamine Agonists
  • Dystonia
  • Female
  • Humans
  • Italy
  • Levodopa
  • Male
  • Middle Aged
  • Parkinson Disease
  • Syndrome


Entra nei temi di ricerca di 'Pisa syndrome in Parkinson disease'. Insieme formano una fingerprint unica.

Cita questo